Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Chemours Company (The) Common Stock (NY:CC)

11.18 +0.01 (+0.09%)
Streaming Delayed Price Updated: 1:41 PM EDT, May 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Chemours Company (The) Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
19 20 Next >
Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter revenue results. 
Via Benzinga
American Eagle Reports Upbeat Earnings, Joins Kroger, Burlington Stores And Other Big Stocks Moving Higher On Thursday
U.S. stocks were higher, with the Dow Jones index gaining more than 150 points on Thursday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Chemours Stock Crashed 37% This Morning
Everything that could have gone wrong for Chemours stock today did go wrong. 
Via The Motley Fool
Chemours Provides Update on Internal Review
From The Chemours Company
Via Business Wire
Chemours (NYSE: CC): Kaplan Fox Investigates Potential Securities Fraud at Chemours Co
NEW YORK, NY - (NewMediaWire) - March 6, 2024 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of The Chemours Company (“Chemours” or the “Company”)... 
Via NewMediaWire
Topics Fraud
Exposures Legal
Chemours (NYSE: CC): Kaplan Fox Investigates Potential Securities Fraud at Chemours Co
NEW YORK, NY - (NewMediaWire) - March 6, 2024 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of The Chemours Company (“Chemours” or the “Company”)... 
Via TheNewswire.com
Topics Fraud
Exposures Legal
CC INVESTIGATION ALERT: Kirby McInerney LLP Continues Investigation on Behalf of The Chemours Company Investors
From Kirby McInerney LLP
Via Business Wire
American Airlines To Rally Around 42%? Here Are 10 Top Analyst Forecasts For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
Bragar Eagel & Squire, P.C. Is Investigating Waldencast, Chemours, Trupanion, and Renovaro and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Renowned Litigation Firm Labaton Keller Sucharow LLP is Investigating The Chemours Company for Securities Violations and Encourages Investors to Contact the Firm
From Labaton Keller Sucharow LLP
Via Business Wire
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages The Chemours Company Investors to Inquire About Securities Class Action Investigation - CC
WHY: NEW YORK, NY - (NewMediaWire) - March 03, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of The Chemours... 
Via NewMediaWire
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages The Chemours Company Investors to Inquire About Securities Class Action Investigation - CC
WHY: NEW YORK, NY - (NewMediaWire) - March 03, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of The Chemours... 
Via TheNewswire.com
Renowned Litigation Firm Labaton Keller Sucharow LLP is Investigating The Chemours Company for Securities Violations and Encourages Investors to Contact the Firm
From Labaton Keller Sucharow
Via Business Wire
ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages The Chemours Company Investors to Inquire About Securities Class Action Investigation – CC
From The Rosen Law Firm PA
Via GlobeNewswire
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages The Chemours Company Investors to Inquire About Securities Class Action Investigation - CC
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages The Chemours Company Investors to Inquire About Securities Class Action Investigation - CC
WHY: NEW YORK, NY - (NewMediaWire) - March 01, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of The Chemours... 
Via TheNewswire.com
Analyst Finds It Difficult To Make Numeric Assumptions For Chemours: Here's Why
BMO analyst downgrades Chemours to Underperform, citing delayed filings, management changes, and difficulty in making earnings assumptions. 
Via Benzinga
Bragar Eagel & Squire, P.C. Is Investigating Chemours, Methanex, and AirSculpt and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Lost Money in the Chemours Company? Gibbs Law Group Investigates Potential Securities Law Violations
From Gibbs Law Group
Via Business Wire
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages The Chemours Company Investors to Inquire About Securities Class Action Investigation - CC
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages The Chemours Company Investors to Inquire About Securities Class Action Investigation - CC
WHY: NEW YORK, NY - (NewMediaWire) - February 29, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of The... 
Via TheNewswire.com
The Law Offices of Frank R. Cruz Continues Investigation of The Chemours Company (CC) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Chemours (NYSE: CC): Kaplan Fox Investigates Potential Securities Fraud at Chemours - Company Executives Placed on Administrative Leave
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud
Exposures Legal
Chemours (NYSE: CC): Kaplan Fox Investigates Potential Securities Fraud at Chemours - Company Executives Placed on Administrative Leave
NEW YORK, NY - (NewMediaWire) - February 29, 2024 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of The Chemours Company (“Chemours” or the “Company”)... 
Via TheNewswire.com
Topics Fraud
Exposures Legal
Wall Street Takes A Breather As Inflation Stays Tamed, AMD Hits Record Highs, Apple Struggles: What's Driving Markets Thursday?
Wall Street exhaled a sigh of relief as the Federal Reserve’s favored gauge of inflation cooled as anticipated in January, quelling fears that an unexpected rise in the Consumer Price Index (CPI) might... 
Via Benzinga
Topics Economy
Exposures Interest Rates
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results. 
Via Benzinga
Berman Tabacco Announces Investigation of The Chemours Company (CC) for Potential Securities Law Violations
From Berman Tabacco
Via GlobeNewswire
Nasdaq Gains 100 Points Following PCE Data
U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 100 points on Thursday. Following the market opening Thursday, the Dow traded down 0.07% to 38,923.11 while the... 
Via Benzinga
Topics Stocks
Exposures US Equities
Chemours Stock Tumbles As Company Reveals Management Shakeup And Financial Struggles
Chemours Company reports prelim results, management changes, and delay in 10-K form. Net sales down, net loss expected. 
Via Benzinga
Why Is Ironwood Pharmaceuticals (IRWD) Stock Down 27% Today?
Ironwood Pharmaceuticals stock is falling on Thursday with investors in IRWD unimpressed by its latest Phase III clinical trial results. 
Via InvestorPlace
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.